Medeiros LJ - Search Results

1

PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma.

Atsaves V, Tsesmetzis N, Chioureas D, Kis L, Leventaki V, Drakos E, Panaretakis T, Grander D, Medeiros LJ, Young KH, Rassidakis GZ. Atsaves V, et al. Among authors: medeiros lj. Leukemia. 2017 Jul;31(7):1633-1637. doi: 10.1038/leu.2017.103. Epub 2017 Mar 27. Leukemia. 2017. PMID: 28344319 No abstract available.

2

Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: results with ALK-11 antibody in 327 untreated patients.

Herling M, Rassidakis GZ, Viviani S, Bonfante V, Giardini R, Gianni M, Morris SW, Cabanillas F, Medeiros LJ, Sarris AH. Herling M, et al. Among authors: medeiros lj. Leuk Lymphoma. 2001 Sep-Oct;42(5):969-79. doi: 10.3109/10428190109097716. Leuk Lymphoma. 2001. PMID: 11697652

3

p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma.

Rassidakis GZ, Thomaides A, Wang S, Jiang Y, Fourtouna A, Lai R, Medeiros LJ. Rassidakis GZ, et al. Among authors: medeiros lj. Leukemia. 2005 Sep;19(9):1663-9. doi: 10.1038/sj.leu.2403840. Leukemia. 2005. PMID: 15990866

4

Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma.

Drakos E, Atsaves V, Li J, Leventaki V, Andreeff M, Medeiros LJ, Rassidakis GZ. Drakos E, et al. Among authors: medeiros lj. Leukemia. 2009 Apr;23(4):784-90. doi: 10.1038/leu.2008.348. Epub 2009 Feb 19. Leukemia. 2009. PMID: 19225536

5

The therapeutic potential of p53 reactivation by nutlin-3a in ALK+ anaplastic large cell lymphoma with wild-type or mutated p53.

Drakos E, Atsaves V, Schlette E, Li J, Papanastasi I, Rassidakis GZ, Medeiros LJ. Drakos E, et al. Among authors: medeiros lj. Leukemia. 2009 Dec;23(12):2290-9. doi: 10.1038/leu.2009.180. Epub 2009 Sep 10. Leukemia. 2009. PMID: 19741726

6

Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).

Drakos E, Singh RR, Rassidakis GZ, Schlette E, Li J, Claret FX, Ford RJ Jr, Vega F, Medeiros LJ. Drakos E, et al. Among authors: medeiros lj. Leukemia. 2011 May;25(5):856-67. doi: 10.1038/leu.2011.28. Epub 2011 Mar 11. Leukemia. 2011. PMID: 21394100 Free PMC article.

7

Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.

Rassidakis GZ, Sarris AH, Herling M, Ford RJ, Cabanillas F, McDonnell TJ, Medeiros LJ. Rassidakis GZ, et al. Among authors: medeiros lj. Am J Pathol. 2001 Aug;159(2):527-35. doi: 10.1016/S0002-9440(10)61724-5. Am J Pathol. 2001. PMID: 11485911 Free PMC article.

8

Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy.

Yao Z, Deng L, Xu-Monette ZY, Manyam GC, Jain P, Tzankov A, Visco C, Bhagat G, Wang J, Dybkaer K, Tam W, Hsi ED, van Krieken JH, Ponzoni M, Ferreri AJM, Møller MB, Winter JN, Piris MA, Fayad L, Liu Y, Song Y, Orlowski RZ, Kantarjian H, Medeiros LJ, Li Y, Cortes J, Young KH. Yao Z, et al. Among authors: medeiros lj. Leukemia. 2018 Feb;32(2):353-363. doi: 10.1038/leu.2017.222. Epub 2017 Jul 12. Leukemia. 2018. PMID: 28745330 Free PMC article.

9

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.

Visco C, Li Y, Xu-Monette ZY, Miranda RN, Green TM, Li Y, Tzankov A, Wen W, Liu WM, Kahl BS, d'Amore ES, Montes-Moreno S, Dybkær K, Chiu A, Tam W, Orazi A, Zu Y, Bhagat G, Winter JN, Wang HY, O'Neill S, Dunphy CH, Hsi ED, Zhao XF, Go RS, Choi WW, Zhou F, Czader M, Tong J, Zhao X, van Krieken JH, Huang Q, Ai W, Etzell J, Ponzoni M, Ferreri AJ, Piris MA, Møller MB, Bueso-Ramos CE, Medeiros LJ, Wu L, Young KH. Visco C, et al. Among authors: medeiros lj. Leukemia. 2012 Sep;26(9):2103-13. doi: 10.1038/leu.2012.83. Epub 2012 Mar 22. Leukemia. 2012. PMID: 22437443 Free PMC article.

10

Application of the international prognostic scoring system-revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia.

Ok CY, Hasserjian RP, Fox PS, Stingo F, Zuo Z, Young KH, Patel K, Medeiros LJ, Garcia-Manero G, Wang SA. Ok CY, et al. Among authors: medeiros lj. Leukemia. 2014 Jan;28(1):185-9. doi: 10.1038/leu.2013.191. Epub 2013 Jun 21. Leukemia. 2014. PMID: 23787392 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,284 results

Search Page